GSK Rx division responds to shift toward value-based health care
GlaxoSmithKline is changing the way it operates, both internally and in terms of how it interacts with other health care stakeholders.
CDR
O-T-Cs to empower consumers
Part of the solution to the problems of access and cost that beset the nation’s health care system can be found in greater use of over-the-counter medications, an insight on which GlaxoSmithKline Consumer Healthcare is acting.
For GSK, differentiation through science is cutting-edge
New products are the lifeblood of the consumer products business, and that’s as true in the over-the-counter drug category as in any other sector.
Divine Skin set to manufacture OTC pain reliever
Divine Skin Inc. has been granted a Drug Enforcement Agency license in tandem with its manufacturing partner to produce and distribute and other controlled substances.
GSK adapts to changing pharmaceutical business model
One of the first big drug makers to hit the so-called patent cliff, GlaxoSmithKline (GSK), has responded to a changing industry business model by rethinking its strategic positioning and adopting a more balanced approach to the evolving health care marketplace.
In CDC pilot, Walgreens provides free HIV tests
Walgreen Co. is participating in a Centers for Disease Control and Prevention (CDC) pilot through which it will offer free HIV testing.
Walmart seeks pharmacy hires in Canada
Walmart it has embarked on what it called a "hiring spree" in Canada, including its pharmacies. The discount store giant said Monday that Walmart Canada is opening 47 hiring centers nationwide to support the company’s growth plans and employment of new talent.
Upsher-Smith kicks off national rollout of Provella
Upsher-Smith Laboratories Inc. is under way with the nationwide launch of Provella, a probiotic dietary supplement designed for women to promote digestive, feminine and immune health.
Wasson: Walgreens could be on London exchange
Walgreen Co.’s deal to buy a large stake in Alliance Boots, with the aim of acquiring the company later on, could land the U.S. drug chain’s shares on the London exchange.
Some health reform benefits upheld by insurers
With the fate of the health care reform law hanging in the balance, three of the country’s largest health insurers said they would maintain some Affordable Care Act benefits regardless of how the Supreme Court rules on it.
London Drugs gears up for multichannel commerce
As it prepares to launch a new online store, London Drugs is leveraging an e-commerce solution that will enable the western Canada chain to grow across multiple digital channels. Burlington, Mass.
Walgreens responds to pertussis outbreak in Kansas
Walgreen Co. is facilitating access to immunizations for whooping cough at its drug stores in Kansas and Missouri, where authorities are reporting epidemic levels of the highly contagious respiratory infection.
APhA gets pharmacists involved in BP control
The American Pharmacists Association (APhA) Foundation has launched the Pharmacy Blood Pressure Challenge, a screening and education initiative that urges pharmacists to help prevent and control high blood pressure.
NACDS’ Jaeger: Pharmacy can transform health care
Retail pharmacy has the capacity to be one of the drivers of the transformation of health care, says Kathleen Jaeger, senior vice president of pharmacy care and patient advocacy at the National Association of Chain Drug Stores.
Katz CEO Scorpiniti energized by intense competition
Frank Scorpiniti is now just over a year into his Canadian experience: 11 months as chief operating officer of the Katz Group and just four months in the chief executive officer position to which he was appointed after the retirement of former president and CEO Andy Giancamilli in February.
Insurers to preserve key reform elements
With the fate of the health care reform law hanging in the balance, three of the country’s largest health insurers said they would maintain some Affordable Care Act benefits regardless of how the Supreme Court rules on it.